The integration of AI technologies and biomedicine can speed up new drug clinical trials and improve the success rate, which has been the trend of biomedical development and has become the core competitiveness of the biopharmaceutical industry.

With the mission of "challenging the future with 3D innovation", Great Bay Bio combines big data, AI technologies and interdisciplinary technologies with biological development, applies cutting-edge technologies to biopharmaceutical processes including target discovery, drug design, process technique optimization, process scale-up, formulation research, and automated control, changes drug researches from hypothesis-driven to data-driven, and makes it possible to realize the industrialization of biotechnology and pharmaceutical innovation.